What is it about?
Sofosbuvir&ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
Featured Image
Why is it important?
Treatment of chronic hepatitis C genotype 4 infection
Perspectives
Sofosbuvir and ledipasvir treatment for 12 weeks was well tolerated by patients with HCV genotype 4 and resulted in 99% SVR for all patients who received 12 weeks of the study drugs.
sherief Abd-Elsalam
Tanta University
Read the Original
This page is a summary of: Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection, Infection and Drug Resistance, March 2018, Dove Medical Press,
DOI: 10.2147/idr.s153060.
You can read the full text:
Contributors
The following have contributed to this page
